(Q33239031)

24 July 2017

title

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody (English)

1 reference

spike glycoprotein [SARS-Cov]

24 July 2017

1 reference

1 reference

inferred from abstract

1 reference

inferred from abstract

0 references

1 reference

Xinhua Ji

7

0 references

author name string

Ponraj Prabakaran

1

1 reference

24 July 2017

Jianhua Gan

2

1 reference

24 July 2017

Yang Feng

3

1 reference

24 July 2017

Zhongyu Zhu

4

1 reference

24 July 2017

Vidita Choudhry

5

1 reference

24 July 2017

Xiaodong Xiao

6

1 reference

24 July 2017

Dimiter S Dimitrov

8

1 reference

24 July 2017

language of work or name

English

0 references

publication date

5 April 2006

1 reference

Journal of Biological Chemistry

24 July 2017

published in

1 reference

24 July 2017

volume

281

1 reference

24 July 2017

issue

23

1 reference

24 July 2017

page(s)

15829-15836

1 reference

A novel coronavirus associated with severe acute respiratory syndrome

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

SARS-Associated Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Virus entry: molecular mechanisms and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

How Viruses Enter Animal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

The SARS-CoV S glycoprotein: expression and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

The SARS-CoV S glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

21 January 2018

SARS vaccine development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Antibodies, viruses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Structural basis of West Nile virus neutralization by a therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Likelihood-enhanced fast rotation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

New applications of simulated annealing in X-ray crystallography and solution NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

AMoRe: an automated package for molecular replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Antibody-antigen interactions: new structures and new conformational changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Structure of a V3-containing HIV-1 gp120 core

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Shape complementarity at protein/protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Interactions of protein antigens with antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Antibody elbow angles are influenced by their light chain class

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Bats are natural reservoirs of SARS-like coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600697200

21 January 2018

Identifiers

DOI

10.1074/JBC.M600697200

1 reference

24 July 2017

1 reference